Diagnostic precision in clinical laboratories: biochemical biomarkers and rapid microbiological methods for adult sepsis and bloodstream infection; a systematic review
DOI:
https://doi.org/10.65759/b8j4jz75Keywords:
Clinical laboratory science, clinical biochemistry, clinical microbiology, sepsis, bloodstream infectionAbstract
Background: Discrimination of bacterial sepsis from sterile inflammation and early identification of bloodstream pathogens are important laboratory tasks. Biochemical biomarkers describe host response, whereas molecular assays and mass spectrometry detect or identify pathogens. Objective: To evaluate the diagnostic performance and clinical utility of biochemical biomarkers and rapid microbiological methods in adults with suspected sepsis or bloodstream infection. Methods: A search framework covering PubMed, Scopus, Web of Science, and Cochrane Library was applied to August 2026. Studies assessed C-reactive protein, procalcitonin, presepsin, multimarker panels, multiplex polymerase chain reaction, or matrix-assisted laser desorption time of flight mass spectrometry in adults. Outcomes included diagnostic accuracy, pathogen yield, identification time, antimicrobial optimization, length of stay, and mortality. Results: Ten studies involving 4,425 patients were included. Multimarker panels produced stronger discrimination in severe presentations than individual markers, while procalcitonin outperformed presepsin and C reactive protein for culture-confirmed infection. Multiplex polymerase chain reaction accelerated or increased pathogen detection but retained discordance with blood culture. Stewardship-linked rapid identification shortened therapy-optimization intervals. Clinical outcome effects were less consistent than workflow effects. Conclusion: Biochemical and microbiological methods provide complementary rather than interchangeable information. Diagnostic precision rests on validated assays, specimen quality controls, conventional culture, clinical context, specialist interpretation, and rapid communication.
References
1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287.
2. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211. doi:10.1016/S0140-6736(19)32989-7.
3. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247. doi:10.1007/s00134-021-06506-y.
4. Lamy B, Dargère S, Arendrup MC, Parienti JJ, Tattevin P. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A state-of-the art. Front Microbiol. 2016;7:697. doi:10.3389/fmicb.2016.00697.
5. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care. 2010;14(1):R15. doi:10.1186/cc8872.
6. Sinha M, Jupe J, Mack H, Coleman TP, Lawrence SM, Fraley SI. Emerging technologies for molecular diagnosis of sepsis. Clin Microbiol Rev. 2018;31(2):e00089-17. doi:10.1128/CMR.00089-17.
7. Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57(Suppl 3):S139–S170. doi:10.1093/cid/cit578.
8. Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1–e94. doi:10.1093/cid/ciy381.
9. Kofoed K, Andersen O, Kronborg G, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care. 2007;11(2):R38. doi:10.1186/cc5723.
10. Ulla M, Pizzolato E, Lucchiari M, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care. 2013;17(4):R168. doi:10.1186/cc12847.
11. Behnes M, Bertsch T, Lepiorz D, et al. Diagnostic and prognostic utility of soluble CD14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care. 2014;18(5):507. doi:10.1186/s13054-014-0507-z.
12. Ljungström L, Pernestig AK, Jacobsson G, Andersson R, Usener B, Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS One. 2017;12(7):e0181704. doi:10.1371/journal.pone.0181704.
13. Park J, Yoon JH, Ki HK, Ko JH, Moon HW. Performance of presepsin and procalcitonin predicting culture-proven bacterial infection and 28-day mortality: a cross-sectional study. Front Med (Lausanne). 2022;9:954114. doi:10.3389/fmed.2022.954114.
14. Tsalik EL, Jones D, Nicholson B, et al. Multiplex PCR to diagnose bloodstream infections in patients admitted from the emergency department with sepsis. J Clin Microbiol. 2010;48(1):26–33. doi:10.1128/JCM.01447-09.
15. Wallet F, Nseir S, Baumann L, et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect. 2010;16(6):774–779. doi:10.1111/j.1469-0691.2009.02940.x.
16. Herne V, Nelovkov A, Kütt M, Ivanova M. Diagnostic performance and therapeutic impact of LightCycler SeptiFast assay in patients with suspected sepsis. Eur J Microbiol Immunol (Bp). 2013;3(1):68–76. doi:10.1556/EuJMI.3.2013.1.10.
17. Huang AM, Newton D, Kunapuli A, et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis. 2013;57(9):1237–1245. doi:10.1093/cid/cit498.
18. Banerjee R, Teng CB, Cunningham SA, et al. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis. 2015;61(7):1071–1080. doi:10.1093/cid/civ447.
19. Wu CC, Lan HM, Han ST, et al. Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis. Ann Intensive Care. 2017;7:91. doi:10.1186/s13613-017-0316-z.
20. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(5):426–435. doi:10.1016/S1473-3099(12)70323-7.
21. Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis. 2017;64(1):15–23. doi:10.1093/cid/ciw649.
22. Buehler SS, Madison B, Snyder SR, et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a Laboratory Medicine Best Practices systematic review and meta-analysis. Clin Microbiol Rev. 2016;29(1):59–103. doi:10.1128/CMR.00053-14.
